← Back to Influence Map
Entity DossierOrganization
Cure Alzheimer's Fund
MA
501(c)(3) organization. Received $500,000 grant in 2022. Purpose: See Part IV
Tracked direct giving
$0
Tracked donations to candidate
$0
Connections
50
Dark Money Spending
Election spending by organizations that do not disclose their donors. Dark money flows through 501(c)(4) social welfare organizations, 501(c)(6) trade associations, and similar entities that are not required to reveal their funders. Figures below are never combined with disclosed-donor totals.
IRS 990 Schedule I Grant Chain
Grants between nonprofits reported on IRS Form 990 Schedule I. These inter-organizational transfers are a key pathway in dark money flows — a nonprofit may receive a grant from one entity and then spend that money on election ads.
IRS 990 Schedule I grants given
$9,592,891
| Grantee | Amount | Tax Year | Purpose |
|---|---|---|---|
| Boston University | $287,500 | 2023 | APOE CONSORTIUM: MODULATION OF SELECTIVE NEURONAL VULNERABILITY IN ALZHEIMER'S DISEASE BY APOE |
| Columbia University | $201,250 | 2023 | NONCODING TRANSLATION FEEDBACK LOOP IN ALZHEIMER'S DISEASE |
| Massachusetts Institute of Technology | $300,000 | 2023 | CIRCUITS: DISSECTING MICROGLIAL STATE DYNAMICS IN ALZHEIMER'S DISEASE |
| U C SAN DIEGO FOUNDATION | $287,500 | 2023 | NIC: MECHANISMS MEDIATING MICROGLIA SENSING OF PERIPHERAL INFLAMMATION |
| Beth Israel Deaconess Medical Center Inc | $118,450 | 2023 | AGP: GENOMIC VARIANT CALLING AND DATA MANAGEMENT FOR THE CURE ALZHEIMER'S FUND ALZHEIMER'S GENOME PROJECT |
| Brigham and Women's Hospital | $287,500 | 2023 | APOE CONSORTIUM: APOE4-MEDIATED DYSFUNCTION OF CD8 T CELL-MICROGLIA CROSSTALK IN ALZHEIMER'S DISEASE |
| Duke University School of Medicine | $229,994 | 2023 | UTILITY OF BLOOD BASED MARKERS FOR PREDICTING ARIA AND ITS COURSE IN MCI AND AD SUBJECTS UNDERGOING ROUTINE CLINICAL TREATMENT WITH AMYLOID-DIRECTED ANTIBODIES |
| EMORY UNIVERSITY | $201,250 | 2023 | MITOCHONDRIAL ALZHEIMER'S RISK FACTORS CONTROL APOE EXPRESSION AND SECRETION |
| METHODIST HOSPITAL | $201,199 | 2023 | A MUTI-MODALITY STUDY ON LIPID MOLECULAR BASIS OF OBESITY AND ITS ROLES IN REGULATING ALZHEIMER'S PATHOGENESIS FOR DEVELOPING POTENTIAL TARGETED INTERVENTIONS |
| TRUSTEES OF TUFTS COLLEGE | $201,250 | 2023 | MULTIDISCIPLINARY PHENOTYPING OF A NOVEL HUMANIZED LOAD MOUSE MODEL |
| UNIVERSITY OF CHICAGO | $250,000 | 2023 | MBC: TEMPORAL RELATIONSHIPS BETWEEN GUT DYSBIOSIS, BRAIN AB METABOLISM AND MICROGLIA CELL ACTIVATION FOLLOWING ANTIBIOTIC TREATMENT |
| Harvard University | $40,250 | 2023 | GENETIC ANCESTRY-SPECIFIC RISK ESTIMATION OF ALZHEIMER'S DISEASE (AD) IN THE APOE REGION |
| NYU SCHOOL OF MEDICINE | $208,033 | 2023 | MECHANISMS OF ASTROCYTE-DERIVED LIPID TOXICITY IN ALZHEIMER'S DISEASE |
| NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE | $172,500 | 2023 | T CELL EPIGENETICS IN ALZHEIMER'S DISEASE |
| Hoover Institution | $201,250 | 2023 | MULTIOMICS CHARACTERIZATION OF TAU PATHOLOGY ONSET AND ITS RELATIONSHIP WITH AMYLOID IN THE HUMAN HIPPOCAMPUS |
| UNIVERSITY OF TEXAS HEALTH SCIENCE CNTR | $201,250 | 2023 | IDENTIFICATION AND VALIDATION OF PLASMA-BASED LIPID BIOMARKERS FOR EARLY ALZHEIMER'S DISEASE IN THE UNIQUE, PRIMARILY HISPANIC, SOUTH TEXAS POPULATION |
| CHILDRENS HOSPITAL CORPORATION | $344,085 | 2023 | NIC: EFFECTS OF PERIPHERAL INFLAMMATION ON MYELOID CELL FUNCTION IN ALZHEIMER'S DISEASE |
| Icahn School of Medicine at Mount Sinai | $172,500 | 2023 | IN VIVO MODELS FOR GOLGI FRAGMENTATION AND THE MOLECULAR PATHOGENESIS OF ALZHEIMER'S DISEASE |
| MAYO CLINIC IN JACKSONVILLE | $201,250 | 2023 | RESTORE MENINGEAL LYMPHATIC DRAINAGE TO ALLEVIATE WHITE MATTER DAMAGE AND CEREBRAL AMYLOID ANGIOPATHY IN A MODEL OF ALZHEIMER'S DISEASE |
| MEMORIAL SLOAN KETTERING CANCER CENTER | $230,000 | 2023 | THE ROLE OF IFITM3 AND Y-SECRETASE IN MICROGLIA |
| UNIVERSITY OF CALIFORNIA AT DAVIS | $201,250 | 2023 | NEURONAL MECHANISMS DRIVING SYNAPSE LOSS IN ALZHEIMER'S DISEASE |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE | $287,493 | 2023 | NIC: EXAMINING THE IMPACT OF PERIPHERALLY DERIVED HUMAN MACROPHAGES IN AD PATHOGENESIS |
| The Broad Institute Inc | $172,550 | 2023 | REVEALING NEW GENES AND PATHWAYS AT THE INTERSECTION OF LIPOTOXIC AND GENETIC RISK FOR ALZHEIMER'S DISEASE |
| UT Southwestern Medical Center | $287,000 | 2023 | ADTC: ROLE OF VCP/P97 IN TAU PRION REPLICATION |
| WASHINGTON UNIVERSITY IN ST LOUIS | $113,655 | 2023 | CHARACTERIZATION OF MOLECULAR BIOMARKER PROFILES THROUGHOUT THE PATHOBIOLOGICAL CONTINUUM |
| Yale University | $204,081 | 2023 | BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMER'S DISEASE CHARACTERIZED BY MRI |
| JOHNS HOPKINS UNIVERSITY CENTRAL LOCKBOX | $201,250 | 2023 | HUMAN BRAIN CD33 LIGAND, RPTPS3L, LIMITS MICROGLIAL PHAGOCYTOSIS AND CONTRIBUTES TO ALZHEIMER'S DISEASE PROGRESSION |
| MASSACHUSETTS GENERAL HOSPITAL THE | $1,955,000 | 2023 | THE CUREALZ ALZHEIMER'S GENOME PROJECT |
| SALK INSTITUTE FOR BIOLOGICAL STUDIES | $201,250 | 2023 | TO ELUCIDATE THE ROLE OF MEMORY T CELLS AS A DETERMINANT OF AGE-RELATED INFLAMMATION IN ALZHEIMER'S DISEASE |
| UNIVERSITY OF RHODE ISLAND | $201,250 | 2023 | EFFECT OF APOE GENOTYPE IN A NOVEL RAT MODEL OF CEREBRAL AMYLOID ANGIOPATHY |
| University of Connecticut | $230,000 | 2023 | AD PATHOPHYSIOLOGY ALTERS THE LEVEL OF ELECTRICAL AND CHEMICAL SYNAPSE COUPLING IN THE NETWORK OF GABAERGIC PV+ INTERNEURONS EARLY IN DISEASE COURSE |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | $201,250 | 2023 | MORPHOLOGICAL, ELECTROPHYSIOLOGICAL, AND TRANSCRIPTIONAL CHARACTERIZATION OF SINGLE NEURONS FROM RESILIENT AND SUSCEPTIBLE MODELS OF HUMAN AD |
| RECTOR AND VISITORS OF THE UNIVERSITY | $192,020 | 2023 | TOXIC EFFECTS OF EXTRACELLULAR TAU OLIGOMERS ON NEURONS |
| New York Weill Cornell Med Ctr Fdn | $201,250 | 2023 | IDENTIFICATION AND DEVELOPMENT OF CD33 INHIBITORS AND PRE-RNA SPLICING MODULATORS |
| University of Southern California | $201,250 | 2023 | PRENATAL INFLAMMATION EFFECTS ON BLOOD BRAIN BARRIER FUNCTION AND AD-RELATED PATHOLOGIES ACROSS THE LIFESPAN |
| EMORY | $201,250 | 2023 | MITOCHONDRIAL ALZHEIMER'S RISK FACTORS CONTROL APOE EXPRESSION AND SECRETION |
| YALE UNIVERSITY SCHOOL OF MEDICINE | $204,081 | 2023 | BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMER'S DISEASE CHARACTERIZED BY MRI |
IRS 990 Schedule I grants received
$3,068,648
| Grantor | Amount | Tax Year | Purpose |
|---|---|---|---|
| DAFFY CHARITABLE FUND | $5,500 | 2024 | GENERAL SUPPORT OF MISSION |
| AMERICAN ENDOWMENT FOUNDATION | $83,800 | 2024 | MEDICAL RESEARCH |
| AMERICAN GIFT FUND | $57,085 | 2024 | OPERATIONS |
| CHARITIES AID FOUNDATION AMERICA | $9,328 | 2023 | CHARITABLE DONATION |
| COMMUNITY FOUNDATION OF NEW JERSEY | $20,000 | 2023 | UNRESTRICTED GRANT TO SUPPORT ORGANIZATION'S EXEMPT PURPOSE |
| FJC | $20,000 | 2023 | GENERAL OPERATING SUPPORT |
| AMERICA'S CHARITIES | $5,143 | 2023 | GENERAL SUPPORT |
| AYCO CHARITABLE FOUNDATION | $17,572 | 2023 | MEDICAL / PUBLIC SERVICES |
| Schwab Charitable | $960,967 | 2023 | HEALTH |
| JEWISH NATIONAL FUND -KEREN KAYEMETH LEISRAEL- INC | $20,000 | 2023 | — |
| Fidelity Investments Charitable Gift Fund | $1,324,253 | 2022 | For grant recipient's exempt purposes |
| CALIFORNIA COMMUNITY FOUNDATION | $45,000 | 2022 | HEALTH |
| University of Notre Dame | $500,000 | 2022 | See Part IV |
Source: IRS Form 990 Schedule I (Grants and Other Assistance to Organizations) via ProPublica Nonprofit Explorer and IRS 990 XML e-files. Grant amounts represent the most recent filing year available.
IRS 990 data lags a year or more behind filing. Grants shown are for the stated tax year and do not establish current-cycle funding.
Methodology Disclosure
Dark money figures are derived from FEC Form 5 (independent expenditures by non-committee organizations) and Form 9 (electioneering communications). These filings capture spending on ads and election communications but do not reveal the identity of the organization's donors. QPQ totals may differ from benchmarks like the Brennan Center's estimates because QPQ includes all Form 5 filers, while some benchmarks count only a subset of non-disclosing nonprofits. Grant chain data is from IRS Form 990 Schedule I and may not include all years or all grantee organizations.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Gave money to | Boston University | IRS 990 Schedule I grant of $287,500 (tax year 2023). Purpose: APOE CONSORTIUM: MODULATION OF SELECTIVE NEURONAL VULNERABILITY IN ALZHEIMER'S DISEASE BY APOE | Source |
| Gave money to | Columbia University | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: NONCODING TRANSLATION FEEDBACK LOOP IN ALZHEIMER'S DISEASE | Source |
| Gave money to | Massachusetts Institute of Technology | IRS 990 Schedule I grant of $300,000 (tax year 2023). Purpose: CIRCUITS: DISSECTING MICROGLIAL STATE DYNAMICS IN ALZHEIMER'S DISEASE | Source |
| Gave money to | U C SAN DIEGO FOUNDATION | IRS 990 Schedule I grant of $287,500 (tax year 2023). Purpose: NIC: MECHANISMS MEDIATING MICROGLIA SENSING OF PERIPHERAL INFLAMMATION | Source |
| Gave money to | Beth Israel Deaconess Medical Center Inc | IRS 990 Schedule I grant of $118,450 (tax year 2023). Purpose: AGP: GENOMIC VARIANT CALLING AND DATA MANAGEMENT FOR THE CURE ALZHEIMER'S FUND ALZHEIMER'S GENOME PROJECT | Source |
| Gave money to | Brigham and Women's Hospital | IRS 990 Schedule I grant of $287,500 (tax year 2023). Purpose: APOE CONSORTIUM: APOE4-MEDIATED DYSFUNCTION OF CD8 T CELL-MICROGLIA CROSSTALK IN ALZHEIMER'S DISEASE | Source |
| Gave money to | Duke University School of Medicine | IRS 990 Schedule I grant of $229,994 (tax year 2023). Purpose: UTILITY OF BLOOD BASED MARKERS FOR PREDICTING ARIA AND ITS COURSE IN MCI AND AD SUBJECTS UNDERGOING ROUTINE CLINICAL TREATMENT WITH AMYLOID-DIRECTED ANTIBODIES | Source |
| Gave money to | EMORY UNIVERSITY | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: MITOCHONDRIAL ALZHEIMER'S RISK FACTORS CONTROL APOE EXPRESSION AND SECRETION | Source |
| Gave money to | METHODIST HOSPITAL | IRS 990 Schedule I grant of $201,199 (tax year 2023). Purpose: A MUTI-MODALITY STUDY ON LIPID MOLECULAR BASIS OF OBESITY AND ITS ROLES IN REGULATING ALZHEIMER'S PATHOGENESIS FOR DEVELOPING POTENTIAL TARGETED INTERVENTIONS | Source |
| Gave money to | TRUSTEES OF TUFTS COLLEGE | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: MULTIDISCIPLINARY PHENOTYPING OF A NOVEL HUMANIZED LOAD MOUSE MODEL | Source |
| Gave money to | UNIVERSITY OF CHICAGO | IRS 990 Schedule I grant of $250,000 (tax year 2023). Purpose: MBC: TEMPORAL RELATIONSHIPS BETWEEN GUT DYSBIOSIS, BRAIN AB METABOLISM AND MICROGLIA CELL ACTIVATION FOLLOWING ANTIBIOTIC TREATMENT | Source |
| Gave money to | Harvard University | IRS 990 Schedule I grant of $40,250 (tax year 2023). Purpose: GENETIC ANCESTRY-SPECIFIC RISK ESTIMATION OF ALZHEIMER'S DISEASE (AD) IN THE APOE REGION | Source |
| Gave money to | NYU SCHOOL OF MEDICINE | IRS 990 Schedule I grant of $208,033 (tax year 2023). Purpose: MECHANISMS OF ASTROCYTE-DERIVED LIPID TOXICITY IN ALZHEIMER'S DISEASE | Source |
| Gave money to | NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE | IRS 990 Schedule I grant of $172,500 (tax year 2023). Purpose: T CELL EPIGENETICS IN ALZHEIMER'S DISEASE | Source |
| Gave money to | Hoover Institution | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: MULTIOMICS CHARACTERIZATION OF TAU PATHOLOGY ONSET AND ITS RELATIONSHIP WITH AMYLOID IN THE HUMAN HIPPOCAMPUS | Source |
| Gave money to | UNIVERSITY OF TEXAS HEALTH SCIENCE CNTR | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: IDENTIFICATION AND VALIDATION OF PLASMA-BASED LIPID BIOMARKERS FOR EARLY ALZHEIMER'S DISEASE IN THE UNIQUE, PRIMARILY HISPANIC, SOUTH TEXAS POPULATION | Source |
| Gave money to | CHILDRENS HOSPITAL CORPORATION | IRS 990 Schedule I grant of $344,085 (tax year 2023). Purpose: NIC: EFFECTS OF PERIPHERAL INFLAMMATION ON MYELOID CELL FUNCTION IN ALZHEIMER'S DISEASE | Source |
| Gave money to | Icahn School of Medicine at Mount Sinai | IRS 990 Schedule I grant of $172,500 (tax year 2023). Purpose: IN VIVO MODELS FOR GOLGI FRAGMENTATION AND THE MOLECULAR PATHOGENESIS OF ALZHEIMER'S DISEASE | Source |
| Gave money to | MAYO CLINIC IN JACKSONVILLE | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: RESTORE MENINGEAL LYMPHATIC DRAINAGE TO ALLEVIATE WHITE MATTER DAMAGE AND CEREBRAL AMYLOID ANGIOPATHY IN A MODEL OF ALZHEIMER'S DISEASE | Source |
| Gave money to | MEMORIAL SLOAN KETTERING CANCER CENTER | IRS 990 Schedule I grant of $230,000 (tax year 2023). Purpose: THE ROLE OF IFITM3 AND Y-SECRETASE IN MICROGLIA | Source |
| Gave money to | UNIVERSITY OF CALIFORNIA AT DAVIS | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: NEURONAL MECHANISMS DRIVING SYNAPSE LOSS IN ALZHEIMER'S DISEASE | Source |
| Gave money to | REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE | IRS 990 Schedule I grant of $287,493 (tax year 2023). Purpose: NIC: EXAMINING THE IMPACT OF PERIPHERALLY DERIVED HUMAN MACROPHAGES IN AD PATHOGENESIS | Source |
| Gave money to | The Broad Institute Inc | IRS 990 Schedule I grant of $172,550 (tax year 2023). Purpose: REVEALING NEW GENES AND PATHWAYS AT THE INTERSECTION OF LIPOTOXIC AND GENETIC RISK FOR ALZHEIMER'S DISEASE | Source |
| Gave money to | UT Southwestern Medical Center | IRS 990 Schedule I grant of $287,000 (tax year 2023). Purpose: ADTC: ROLE OF VCP/P97 IN TAU PRION REPLICATION | Source |
| Gave money to | WASHINGTON UNIVERSITY IN ST LOUIS | IRS 990 Schedule I grant of $113,655 (tax year 2023). Purpose: CHARACTERIZATION OF MOLECULAR BIOMARKER PROFILES THROUGHOUT THE PATHOBIOLOGICAL CONTINUUM | Source |
| Gave money to | Yale University | IRS 990 Schedule I grant of $204,081 (tax year 2023). Purpose: BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMER'S DISEASE CHARACTERIZED BY MRI | Source |
| Gave money to | JOHNS HOPKINS UNIVERSITY CENTRAL LOCKBOX | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: HUMAN BRAIN CD33 LIGAND, RPTPS3L, LIMITS MICROGLIAL PHAGOCYTOSIS AND CONTRIBUTES TO ALZHEIMER'S DISEASE PROGRESSION | Source |
| Gave money to | MASSACHUSETTS GENERAL HOSPITAL THE | IRS 990 Schedule I grant of $1,955,000 (tax year 2023). Purpose: THE CUREALZ ALZHEIMER'S GENOME PROJECT | Source |
| Gave money to | SALK INSTITUTE FOR BIOLOGICAL STUDIES | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: TO ELUCIDATE THE ROLE OF MEMORY T CELLS AS A DETERMINANT OF AGE-RELATED INFLAMMATION IN ALZHEIMER'S DISEASE | Source |
| Gave money to | UNIVERSITY OF RHODE ISLAND | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: EFFECT OF APOE GENOTYPE IN A NOVEL RAT MODEL OF CEREBRAL AMYLOID ANGIOPATHY | Source |
| Gave money to | University of Connecticut | IRS 990 Schedule I grant of $230,000 (tax year 2023). Purpose: AD PATHOPHYSIOLOGY ALTERS THE LEVEL OF ELECTRICAL AND CHEMICAL SYNAPSE COUPLING IN THE NETWORK OF GABAERGIC PV+ INTERNEURONS EARLY IN DISEASE COURSE | Source |
| Gave money to | REGENTS OF THE UNIVERSITY OF MICHIGAN | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: MORPHOLOGICAL, ELECTROPHYSIOLOGICAL, AND TRANSCRIPTIONAL CHARACTERIZATION OF SINGLE NEURONS FROM RESILIENT AND SUSCEPTIBLE MODELS OF HUMAN AD | Source |
| Gave money to | RECTOR AND VISITORS OF THE UNIVERSITY | IRS 990 Schedule I grant of $192,020 (tax year 2023). Purpose: TOXIC EFFECTS OF EXTRACELLULAR TAU OLIGOMERS ON NEURONS | Source |
| Gave money to | New York Weill Cornell Med Ctr Fdn | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: IDENTIFICATION AND DEVELOPMENT OF CD33 INHIBITORS AND PRE-RNA SPLICING MODULATORS | Source |
| Gave money to | University of Southern California | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: PRENATAL INFLAMMATION EFFECTS ON BLOOD BRAIN BARRIER FUNCTION AND AD-RELATED PATHOLOGIES ACROSS THE LIFESPAN | Source |
| Gave money to | EMORY | IRS 990 Schedule I grant of $201,250 (tax year 2023). Purpose: MITOCHONDRIAL ALZHEIMER'S RISK FACTORS CONTROL APOE EXPRESSION AND SECRETION | Source |
| Gave money to | YALE UNIVERSITY SCHOOL OF MEDICINE | IRS 990 Schedule I grant of $204,081 (tax year 2023). Purpose: BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMER'S DISEASE CHARACTERIZED BY MRI | Source |
| Received money from | University of Notre Dame | IRS 990 Schedule I grant of $500,000 (tax year 2022). Purpose: See Part IV | Source |
| Received money from | AMERICAN ENDOWMENT FOUNDATION | IRS 990 Schedule I grant of $83,800 (tax year 2024). Purpose: MEDICAL RESEARCH | Source |
| Received money from | AMERICAN GIFT FUND | IRS 990 Schedule I grant of $57,085 (tax year 2024). Purpose: OPERATIONS | Source |
| Received money from | AMERICA'S CHARITIES | IRS 990 Schedule I grant of $5,143 (tax year 2023). Purpose: GENERAL SUPPORT | Source |
| Received money from | AYCO CHARITABLE FOUNDATION | IRS 990 Schedule I grant of $17,572 (tax year 2023). Purpose: MEDICAL / PUBLIC SERVICES | Source |
| Received money from | CALIFORNIA COMMUNITY FOUNDATION | IRS 990 Schedule I grant of $45,000 (tax year 2022). Purpose: HEALTH | Source |
| Received money from | CHARITIES AID FOUNDATION AMERICA | IRS 990 Schedule I grant of $9,328 (tax year 2023). Purpose: CHARITABLE DONATION | Source |
| Received money from | COMMUNITY FOUNDATION OF NEW JERSEY | IRS 990 Schedule I grant of $20,000 (tax year 2023). Purpose: UNRESTRICTED GRANT TO SUPPORT ORGANIZATION'S EXEMPT PURPOSE | Source |
| Received money from | DAFFY CHARITABLE FUND | IRS 990 Schedule I grant of $5,500 (tax year 2024). Purpose: GENERAL SUPPORT OF MISSION | Source |
| Received money from | Schwab Charitable | IRS 990 Schedule I grant of $960,967 (tax year 2023). Purpose: HEALTH | Source |
| Received money from | Fidelity Investments Charitable Gift Fund | IRS 990 Schedule I grant of $1,324,253 (tax year 2022). Purpose: For grant recipient's exempt purposes | Source |
| Received money from | JEWISH NATIONAL FUND -KEREN KAYEMETH LEISRAEL- INC | IRS 990 Schedule I grant of $20,000 (tax year 2023) | Source |
| Received money from | FJC | IRS 990 Schedule I grant of $20,000 (tax year 2023). Purpose: GENERAL OPERATING SUPPORT | Source |